ES2115188T3 - Tabletas de oxcarbazepina doblemente recubiertas. - Google Patents

Tabletas de oxcarbazepina doblemente recubiertas.

Info

Publication number
ES2115188T3
ES2115188T3 ES94810494T ES94810494T ES2115188T3 ES 2115188 T3 ES2115188 T3 ES 2115188T3 ES 94810494 T ES94810494 T ES 94810494T ES 94810494 T ES94810494 T ES 94810494T ES 2115188 T3 ES2115188 T3 ES 2115188T3
Authority
ES
Spain
Prior art keywords
double coated
oxcarbazepine
oxcarbazepine tablets
tablets
hydrophilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94810494T
Other languages
English (en)
Inventor
Jacques Bourquin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Novartis AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2115188T3 publication Critical patent/ES2115188T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A TABLETAS DE COLORACION ESTABLE PARA OXCARBAZEPINA COMO SUSTANCIA ACTIVA CON BUEN RESULTADO, QUE JUNTAMENTE CON UN RECUBRIMIENTO INTERIOR PERMEABLE HIDROFILO CONTIENE PIGMENTO DE COLORACION BLANCA Y UN RECUBRIMIENTO EXTERIOR PERMEABLE, HIDROFILO, TENIENDO PIGMENTO DE COLORACION BLANCA COMBINADO CON HIERRO N.
ES94810494T 1993-09-08 1994-08-30 Tabletas de oxcarbazepina doblemente recubiertas. Expired - Lifetime ES2115188T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH267993 1993-09-08

Publications (1)

Publication Number Publication Date
ES2115188T3 true ES2115188T3 (es) 1998-06-16

Family

ID=4239144

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94810494T Expired - Lifetime ES2115188T3 (es) 1993-09-08 1994-08-30 Tabletas de oxcarbazepina doblemente recubiertas.

Country Status (14)

Country Link
US (2) US5472714A (es)
EP (1) EP0646374B1 (es)
JP (1) JP3636380B2 (es)
KR (1) KR100319351B1 (es)
AT (1) ATE164762T1 (es)
AU (1) AU678492B2 (es)
CA (1) CA2131495C (es)
DE (1) DE59405627D1 (es)
ES (1) ES2115188T3 (es)
IL (1) IL110863A (es)
NZ (1) NZ264407A (es)
PH (1) PH30478A (es)
SG (1) SG44498A1 (es)
ZA (1) ZA946874B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
SE9401738D0 (sv) * 1994-05-19 1994-05-19 Ewos Ab Bioactive feed
US6156340A (en) * 1996-03-29 2000-12-05 Duquesne University Of The Holy Ghost Orally administrable time release drug containing products
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
US20020022056A1 (en) * 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
KR19980077329A (ko) * 1997-04-18 1998-11-16 이범진 이중층 약물 함유 제어방출성 제제
GB9721497D0 (en) * 1997-10-09 1997-12-10 Ciba Geigy Ag Organic compounds
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
GB9925962D0 (en) * 1999-11-02 1999-12-29 Novartis Ag Organic compounds
GB9930058D0 (en) * 1999-12-20 2000-02-09 Novartis Ag Organic compounds
US6242003B1 (en) * 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) * 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
WO2002094774A2 (en) * 2001-05-18 2002-11-28 Ranbaxy Laboratories Limited Oxcarbazepine dosage forms
EP1395338B1 (en) * 2001-06-15 2010-12-22 Uv-Solutions, Llc Method for determining the transmissivity of a bandage
US7125563B2 (en) * 2002-04-12 2006-10-24 Dava Pharmaceuticals, Inc. Sustained release pharmaceutical preparations and methods for producing the same
AU2003240654A1 (en) * 2002-05-31 2003-12-19 Desitin Arzneimittel Gmbh Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
WO2004014391A1 (en) * 2002-08-06 2004-02-19 Novartis Ag Use of carboxamides for the treatment of tinnitus
GB0221956D0 (en) * 2002-09-20 2002-10-30 Novartis Ag Organic compounds
FR2846009B1 (fr) * 2002-10-18 2007-10-12 Centre Nat Rech Scient Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees
FR2846008B1 (fr) * 2002-10-18 2006-06-02 Centre Nat Rech Scient Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees
US20050208108A1 (en) * 2004-03-19 2005-09-22 Jannusch Leonard C Thermoplastic films and methods for making
AR048318A1 (es) * 2004-03-22 2006-04-19 Novartis Ag Formulaciones de matriz orales que comprenden licarbazepina
WO2006046105A1 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Oxcarbazepine dosage forms
US20060111343A1 (en) * 2004-11-01 2006-05-25 Glenmark Pharmaceuticals Limited Oxcarbazepine dosage forms
WO2006070406A1 (en) * 2004-12-29 2006-07-06 J.B. Chemicals & Pharmaceuticals Ltd Bilayer tablets of oxcarbazepine for controlled delivery and a process of preparation thereof
US20060252745A1 (en) * 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
WO2007008576A2 (en) * 2005-07-08 2007-01-18 Taro Pharmaceuticals U.S.A., Inc. Oxcarbazepine formulation
US9198862B2 (en) * 2005-07-22 2015-12-01 Rubicon Research Private Limited Dispersible tablet composition
US20070248684A1 (en) * 2006-01-31 2007-10-25 Sigal Blau Pharmaceutical formulations of oxcarbazepine and methods for its preparation
EP1815849A1 (en) * 2006-01-31 2007-08-08 Teva Pharmaceutical Industries Ltd Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
JP2008540346A (ja) * 2006-01-31 2008-11-20 テバ ファーマシューティカル インダストリーズ リミティド オキシカルバゼピンの医薬製剤及びその調製方法
ES2360423T3 (es) 2006-04-26 2011-06-03 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal.
EP2018157A2 (en) 2006-04-26 2009-01-28 Astron Research Limited Controlled release formulation comprising anti-epileptic drugs
US20080138403A1 (en) * 2006-12-08 2008-06-12 Sun Pharmaceutical Industries Ltd. Pharmaceutical dosage forms of oxcarbazepine
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
CN103735527B (zh) * 2013-12-24 2014-09-10 武汉人福药业有限责任公司 一种奥卡西平片剂及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500196A (de) * 1969-03-10 1970-12-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
CH605791A5 (es) * 1974-09-27 1978-10-13 Ciba Geigy Ag
FI75561C (fi) * 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
US4543370A (en) * 1979-11-29 1985-09-24 Colorcon, Inc. Dry edible film coating composition, method and coating form
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS60105611A (ja) * 1983-11-14 1985-06-11 Nippon Chemiphar Co Ltd ニフエジピン軟カプセル剤
DE3541304A1 (de) * 1985-11-22 1987-05-27 Scherer Gmbh R P Orale zubereitungen von knoblauch und verfahren zu ihrer herstellung
US4906638A (en) * 1987-12-22 1990-03-06 Nova Pharmaceutical Corporation Dextromethorphan potentiator for anticonvulsant composition and method
US4931286A (en) * 1989-04-19 1990-06-05 Aqualon Company High gloss cellulose tablet coating
US5248516A (en) * 1989-12-19 1993-09-28 Fmc Corporation Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like
US5198227A (en) * 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
HU206824B (en) * 1990-08-24 1993-01-28 Biogal Gyogyszergyar Process for the production of a table crystallizing in the monoclinic system, which contains light-, heat-, and moisture- sensitive active agents
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
US5231089A (en) * 1991-12-02 1993-07-27 University Of Florida Method of improving oral bioavailability of carbamazepine
US5411746A (en) * 1993-02-24 1995-05-02 Warner-Jenkinson Company, Inc. Dye compositions and methods for film coating tablets and the like
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
JP4375686B2 (ja) * 1998-08-03 2009-12-02 大正製薬株式会社 フィルムコーティング錠剤

Also Published As

Publication number Publication date
EP0646374B1 (de) 1998-04-08
US5472714A (en) 1995-12-05
PH30478A (en) 1997-05-28
JPH07165584A (ja) 1995-06-27
CA2131495C (en) 2006-01-17
EP0646374A1 (de) 1995-04-05
IL110863A0 (en) 1994-11-28
NZ264407A (en) 1995-12-21
DE59405627D1 (de) 1998-05-14
KR100319351B1 (ko) 2002-04-06
ATE164762T1 (de) 1998-04-15
AU7157194A (en) 1995-03-23
JP3636380B2 (ja) 2005-04-06
CA2131495A1 (en) 1995-03-09
SG44498A1 (en) 1997-12-19
KR950007854A (ko) 1995-04-15
AU678492B2 (en) 1997-05-29
ZA946874B (en) 1995-04-24
IL110863A (en) 1999-10-28
US5695782A (en) 1997-12-09

Similar Documents

Publication Publication Date Title
ES2115188T3 (es) Tabletas de oxcarbazepina doblemente recubiertas.
EP1400523A3 (en) Intermediate compounds
CA2266444A1 (en) Olanzapine dihydrate d
CA2191213A1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
ZA966320B (en) Corneal flap/cap elevator.
EP0960107A4 (es)
CA2310585A1 (en) Novel administration form comprising an acid-labile active compound
EP0823993A3 (en) PH-sensitive microcapsules
EP0591925A3 (en) Calibration of an electropneumatic converter.
ZA936552B (en) Color cosmetic composition.
SI1028950T1 (en) 7-substituted quinazolin-2,4-diones useful as antibacterial agents
CA2152771A1 (en) 7-o-ethers of taxane derivatives
CA2118030A1 (en) Drug for increasing the level of testosterone in the body
FI930801L (fi) Foerfarande foer behandling av den flora, som kontaminerar pappersbakteriernas vattenomlopp, medelst bakterier
MX9204623A (es) Compuesto de bis-4-piperidil-fosfita n-metilada.
MX9204811A (es) Pigmento de gamma-quinacridona, modificado.
NZ320259A (en) Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors
MD950171A (en) A Pharmaceutical remedy for impruving or remission - of excitement state during nervous deseases
CA2066191A1 (en) Tricyclic ¬6,5,5|/¬6,6,5|-fused oxazolidinone antibacterial agents
EP0628613A3 (en) Aqueous coating composition.
DE59300756D1 (de) Farbmine.
EP0655487A3 (en) Self-oxidizing water-based coating composition.
IE791212L (en) 2- azaergolines and 2 - aza -8 (or9)- ergolines
DE69403180D1 (de) Sauerstoffundurchlässige Beschichtungszusammensetzung, die trimethoxysilylfunktionalisiertes Pentadienoat enthält
ZA9610841B (en) 2-Pyrazolyloxyphenylacetic acid derivatives, compisitions containing these and their use for fungal and pest control.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 646374

Country of ref document: ES